相关实验视频

Updated: Jul 5, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

核医学治疗药物的比较,针对阿尔法发射核酸中的PSMA

Kazuko Kaneda-Nakashima^1,2,3, Yoshifumi Shirakami^2,3, Yuichiro Kadonaga^2,4

¹Laboratory of Radiation Biological Chemistry, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.

International journal of molecular sciences

|January 23, 2024

概括

向性阿尔法疗法 (TAT) 使用阿尔法发射核酸来杀死癌细胞. 研究人员成功地将前列腺特异性膜抗原 (PSMA) 化合物标记为211At和225Ac,显示211At具有高度的细胞毒性.

科学领域:

核医学和瘤学的核医学和瘤学.
放射性药物化学放射性药物化学

背景情况:

向性阿尔法疗法 (TAT) 为治疗难以治疗的癌症,包括广泛转移的转移性疾病提供了一种新的方法.
众所周知,有几个阿尔法发射核素具有TAT,但对于一些,标记和有限的临床数据存在挑战.
前列腺特异性膜抗原 (PSMA) 是前列腺癌的有前途的治疗标,现有的放射性连接体显示出治疗效果.

研究的目的:

标记前列腺特异性膜抗原 (PSMA) 向化合物与阿尔法发射核素211At和225Ac用于向的阿尔法疗法.
评估和比较211At和225Ac在与PSMA向剂结合时的细胞毒性.
引入和验证一种原始的标签方法 (Shirakami Reaction) 以实现高效的211At集成.

主要方法:

针对前列腺特异性膜抗原 (PSMA) 的化合物被标记为211At和225Ac.
评估了得到的放射性标记结合物的细胞毒性疗效.
一个原始的"希拉卡米反应"被开发并用于211At标签.

主要成果:

标记为211At和225Ac的PSMA向化合物都显示出针对性阿尔法疗法的显著潜力.
211At的细胞毒性与225Ac相当或超过,尽管其半衰期较短.
小说"希拉卡米反应" (Shirakami Reaction) 能够使用211At.At进行快速和高纯度的标签.

结论:

211At是针对针对PSMA表达癌症的向阿尔法疗法的可行和强大的核化物.
开发的Shirakami Reaction为临床前和临床应用提供了高效和有效的211At标签.
这项研究推动了针对前列腺癌和潜在的其他恶性瘤的新型向α疗法的开发.

关键词:

在PSMA上,PSMA可以在PSMA上进行交易.动-22525是一种动.一个statine-21111是什么细胞毒性细胞毒性双链制动器的制动器是双链制动器.生殖能力生殖能力的能力.

更多相关视频

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...